| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.098 | 0.1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.09 | 0.1 |